Evaro raises $25m Series A

January 2026 – Evaro, NHS-licensed digital healthcare platform has just announced a $25m Series A funding round.

• The new capital injection will scale services that make accessing clinically led care simpler and more seamless
  
• It will also expand their business partnerships, including brands such as Clue and Lovehoney Group
  
• The company already serves 2 million patients across the UK, aiming to serve 10 million in the next 3 years

Cornerstone VC returned to participate in the Series A round, 24 months after co-leading the company’s seed round (here). The new round which is being led by AlbionVC, alongside Simplyhealth Ventures, Exceptional Ventures, and BBI is expected to accelerate the companies healthcare-as-a-service model in three core areas. Consumer brands seeking new revenue streams; healthcare organisations expanding digital capacity, and employers offering health benefits to their workforces.

Founded in 2018 by emergency physician Dr. Thuria Wenbar and pharmacist researcher Dr. Oskar Wenbar, Evaro holds comprehensive regulatory credentials: CQC and GPhC licensed since the time of their incorporation, with seven active regulatory approvals and NHS integrations which enable GP record access for safer prescribing.

20.5 million people experienced month-long waits for a GP appointment in 2024, up 60% in seven years. Evaro helps to alleviate the burden on the NHS by providing complete regulated healthcare infrastructure – asynchronous consultations allowing speed and discretion of care, remote diagnostics, prescribing, dispensing, and aftercare – that can be embedded into any platform people spend time on within days. For partners, the model creates a new revenue stream with minimal implementation burden – integrations can be completed in as little as 2 weeks – while deepening customer relationships through an expanded health offering. Evaro’s 4.5 Trustpilot rating reflects strong patient satisfaction.

Dr Thuria Wenbar, Co-founder and CEO of Evaro said

“When a third of people are waiting over a week just to see their GP, it’s time to think through alternative solutions that help people get the care they need while supporting NHS capacity. What we’ve built is infrastructure that allows our partners, brands people already trust, to deliver safe and regulated healthcare for common conditions without having to build a thing.

We’re making healthcare as accessible as online banking, and this funding lets us prove that model works at scale.”

Dr. Oskar Wenbar, Chief Medical Officer and co-founder, added

““Patients now expect the same convenience from healthcare that they get from banking or shopping—instant, mobile, on their terms. The technology exists to deliver this for minor conditions, but our system is still stuck requiring appointments, phone calls, physical visits – with no capacity for smart aftercare.

We want to solve this, and scale the infrastructure that matches how people actually want to access care in 2026.”

Rodney Appiah, Managing Partner at Cornerstone VC, said

“When we led the seed round nearly two years ago, we were struck by Thuria’s ambition to build a healthcare system that is frictionless, patient-first and rooted in people’s everyday lives. By enabling trusted brands to deliver safe, high quality healthcare services, Evaro brings the convenience of shopping and banking to healthcare, underpinned by strong clinical standards.

We believe the future of healthcare is personalised, accessible and convenient, 

and we’re excited to continue backing Thuria and the Evaro team as they scale.”

For more information visit Evaro.